Of course this news was not released in the Japanese national main media nor in the Fukushima local media, it was only released in the Hokkaido Shimbun, a local media from the northern island Hokkaido.
Dr. Kazuo Shimizu
Dr. Kazuo Shimizu, Chairman of the Thyroid Examination Assessment Subcommittee and member of the Oversight Committee for the Fukushima Health Management Survey, a thyroid surgeon and Honorary Director at Kanaji Hospital, and Professor Emeritus at Nippon Medical School, and former chair of the board of the Japanese Society of Thyroid Surgery, submitted his resignation as Chairman of the Thyroid Examination Assessment Subcommittee.
As Chairman of the Thyroid Examination Assessment Subcommittee, he does not personally agree with the interim report conclusion that “it is unlikely that the effects of radiation” caused the high incidence of thyroid cancer found in the Fukushima Prefecture. Not agreeing with the drawn conclusions of the interim report and as Chairman not free to have a personal opinion, nor to express it, he decided to resign.
Dr. Kazuo Shimizu is a doctor, a leading authority in endoscopic surgery of the thyroid gland. Within the Fukushima population, 380,000 children below 18 years old at the time of the Fukushima Daiichi nuclear plant accident in March 2011 have been examined. 174 people have been so far diagnosed with thyroid cancer or suspected thyroid cancer.
Dr. Kazuo Shimizu says that such high incidence of thyroid cancer, from his long clinical experience, is unnatural. That frequency is a fact, which should not be explained, nor discarded by just the “It is unlikely that the effects of radiation.” caused that high incidence conclusion.
In the former Soviet Union after the 1986 Chernobyl nuclear accident, thyroid cancer was frequent in children due the released iodine-131.
However, it is not that surprising. When Oshidori Mako interviewing Dr. Kazuo Shimizu in May 2015 asked « Is it really overdiagnosis that is going on? », Dr. Kazuo Shimizu answered :“I am not in a position to be able to say, ‘It is not due to overdiagnosis.’ As chair of the Subcommittee, I cannot validate opinions of either side. It is hard for me. I would have been able to voice my opinions more clearly if I hadn’t been elected chair of the Subcommittee.”